You are here: Industry Insights > IBD

News List

BiomX raises funds to advance drug candidates for acne and IBD pharmaceutical-technology
February 22, 2019
Israeli drug discovery firm BiomX has raised funds in a series B round to advance its lead acne and inflammatory bowel disease (IBD) drug programmes to the clinic.....
Vedanta nets $27M to move microbiome assets through the clinic fiercebiotech
January 07, 2019
Barely a month after Vedanta Biosciences collected a $12 million payment from Johnson & Johnson, the biotech raised another $27 million in its series C round.....
Post-Inflammatory Polyps Not Linked to Colorectal Neoplasia drugs
December 17, 2018
For patients with inflammatory bowel disease (IBD), post-inflammatory polyps (PIPs) are associated with greater severity and extent of colon inflammation and....
Innovate UK grant for PredictImmune’s IBD drug response test pharmatimes
December 14, 2018
Innovate UK has awarded PredictImmune a £100,000 grant to apply its biomarker-based technology towards the prediction of drug response in IBD.
BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD pharmafocusasia
December 13, 2018
BiomX Ltd., a microbiome company developing customized phage therapies, today announced that it has entered into a collaboration with Janssen Research & Development...
Genentech and Microbiotica to develop new IBD medicines pharmaceutical-technology
June 13, 2018
Genentech has formed a multi-year strategic alliance with Wellcome Sanger Institute’s Microbiotica to address inflammatory bowel disease (IBD).
Protagonist Announces Closing of Janssen License, Collaboration Agreement for PTG-200 americanpharmaceuticalreview
August 28, 2017
Protagonist Therapeutics has closed the worldwide license and collaboration transaction for PTG-200 with Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson
Spoiler alert: IBD superheroes prevail as Takeda wraps its Marvel Comics project fiercepharma
August 08, 2017
Takeda's IBD superheroes are back for the last chapters of its Marvel Comics custom-created graphic novel

Previous page 1 2 3 Next page